RVP vs PNTG vs MCK vs ADUS vs CVS

For growth investors, The Pennant Group, Inc.

(PNTG) is the stronger pick with 36. 3% revenue growth year-over-year, versus -24. 2% for Retractable Technologies, Inc. (RVP). Addus HomeCare Corporation (ADUS) offers the better valuation at 19. 1x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate The Pennant Group, Inc. (PNTG) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 19.

1x versus CVS Health Corporation at 65. 1x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: McKesson Corporation wins at 0. 43x versus The Pennant Group, Inc. 's 2. 66x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +270.

4%, compared to -92. 6% for Retractable Technologies, Inc. (RVP). Over 10 years, the gap is even starker: ADUS returned +411. 7% versus RVP's -70. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at -0.

02β versus The Pennant Group, Inc. 's 0. 75β — meaning PNTG is approximately -4702% more volatile than MCK relative to the S&P 500. On balance sheet safety, Retractable Technologies, Inc. (RVP) carries a lower debt/equity ratio of 1% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), The Pennant Group, Inc.

(PNTG) is pulling ahead at 36. 3% versus -24. 2% for Retractable Technologies, Inc. (RVP). On earnings-per-share growth, the picture is similar: McKesson Corporation grew EPS 49. 2% year-over-year, compared to -66. 7% for Retractable Technologies, Inc.. Over a 3-year CAGR, PNTG leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Addus HomeCare Corporation (ADUS) is the more profitable company, earning 6.

7% net margin versus -36. 0% for Retractable Technologies, Inc. — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9. 7% versus -63. 9% for RVP. At the gross margin level — before operating expenses — ADUS leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, McKesson Corporation (MCK) is the more undervalued stock at a PEG of 0. 43x versus The Pennant Group, Inc. 's 2. 66x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, CVS Health Corporation (CVS) trades at 12. 4x forward P/E versus 26. 7x for The Pennant Group, Inc. — 14. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MCK: 35. 1% to $994. 86.

In this comparison, CVS (3.

0% yield), RVP (1. 1% yield), MCK (0. 4% yield) pay a dividend. PNTG, ADUS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

13), 3. 0% yield). Both have compounded well over 10 years (CVS: +6. 6%, PNTG: +137. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: RVP is a small-cap quality compounder stock; PNTG is a small-cap high-growth stock; MCK is a mid-cap quality compounder stock; ADUS is a small-cap high-growth stock; CVS is a mid-cap quality compounder stock. RVP, CVS pay a dividend while PNTG, MCK, ADUS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.